Loss of Control in Flight · NTSB CEN10FA119
PIPER PA-31T — Forest City, IA
| Date | February 12, 2010 |
| Location | Forest City, IA |
| Aircraft | PIPER PA-31T |
| Purpose of flight | Business |
| Conditions | Day · Visual Meteorological Cond |
| Phase / occurrence | Uncontrolled descent Collision with terr/obj (non-CFIT) |
| Pilot age | 66 |
| Pilot total time | 10,352 hrs · High time |
| Time in type | Unknown |
| Fatalities | 1 |
Probable cause
NTSB findings
- Personnel issues-Task performance-Use of equip/info-Aircraft control-Pilot - C
- Aircraft-Aircraft oper/perf/capability-Performance/control parameters-(general)-Not attained/maintained - C
What happened
A witness reported that the multi-engine turboprop airplane was on final approach to land when it suddenly veered to the left and entered a rapid descent. The witness stated that he heard the "whine of the engines" before the airplane impacted terrain about 1/2 mile south of the runway threshold. In the days preceding the accident flight, the airplane had been at a maintenance facility to resolve a vibration in the rudder system while the autopilot system was engaged. There were no anomalies reported with the autopilot system during a test flight completed immediately before the accident flight. However, anomalies with the rate gyro were noted by a mechanic who recommended replacing it, but the pilot departed on the accident flight without the recommended repair having been completed.
Further, examination of the autopilot annunciator panel indicated that the autopilot was likely not engaged at the time of impact, likely because the airplane was on a short final approach for landing. Accordingly, any existing autopilot faults would not have affected the flight as the autopilot system was likely not in use. There were no failures identified with the primary flight controls, engines, or propellers that would have prevented the pilot from maintaining control of the airplane manually. Toxicological testing revealed the presence of Zolpidem in the pilot's blood (Zolpidem, the trade name for Ambien, is used for short-term treatment of insomnia); however, the reported levels would likely not have resulted in any impairment.